What happened in this Health story?

California's CalRx affordable insulin program has hit pharmacy shelves but seen zero uptake so far, as Governor Newsom publicly champions the initiative while a San Francisco pharmacist reports she hasn't dispensed a single pen.

What is a key fact in this story? (1)

**California's CalRx label** launched long-acting insulin pens marked with the state's grizzly bear logo, but the program is off to a slow start at retail pharmacies.

What is a key fact in this story? (2)

**Margaret On**, a pharmacist at a Walgreens in San Francisco's Japantown neighborhood, stocks two boxes of CalRx insulin pens but has not dispensed any to patients.

📎 SkimNews has covered California 16+ times · see the file →

California's CalRx Insulin Slow to Reach Patients — SkimNews

By STAT News · Summarized & edited by Kapil Samant · 2026-08-13

Get the Health newsletter

Daily health & science — research, biotech, public health, the studies worth knowing. Free.

California's CalRx label launched long-acting insulin pens marked with the state's grizzly bear logo, but the program is off to a slow start at retail pharmacies.
Margaret On, a pharmacist at a Walgreens in San Francisco's Japantown neighborhood, stocks two boxes of CalRx insulin pens but has not dispensed any to patients.
On said she plans to keep the pens on hand for uninsured patients or emergencies, signaling she sees a niche role rather than mainstream demand.
Governor Newsom is publicly promoting CalRx as the state's affordable insulin answer, creating a contrast between the political rollout and the pharmacy-level reality.

Why it matters: The mismatch between Newsom's promotional push and zero dispensings at a stocking pharmacy suggests distribution and awareness — not just manufacturing — are the bottleneck. Until uninsured patients and prescribing physicians actually know about and request CalRx, the program can't deliver the cost relief Newsom is selling.